Due to underrepresentation in health research, our understanding of women’s health is limited. The value of research investment on women’s health is not widely accepted, which has far reaching consequences.
Accelerating and increasing funding for women’s health research is likely to have a significant impact on the health and well-being of everyone. Understanding this impact would provide vital information to funders, researchers, and policymakers to help them plan investments that can yield the greatest public health benefits.
Without information on the potential return on investment (ROI) for women’s health research, research funders, policymakers, and business leaders lack a basis for altering research investments to improve knowledge of women’s health.
The results show that investing in women’s health research can generate gains beyond those achieved through general research. For instance, investing $300 million in women’s health research yields a return of $13 billion to the economy.
Furthermore, even slight health improvements resulting from increased funding for women’s health research can lead to significant returns, such as increased life years, reduced years with disease, fewer years of functional dependence, and less disruption to work productivity.
Femtechnology Summit 2023 Workshop
For the Workshop on Financing Innovation in Women’s Health at the Femtechnology Summit this year, in collaboration with Roche, we want to bring attention to the current funding situation in women’s health. We aim to explore what strategies can be put in place to share the burden of development for novel innovative medicines in women’s health, and how multi-stakeholders can come together to clearly outline hurdles and build new workable paths to innovate on endpoints in underserved women’s health conditions such as endometriosis, PCOS, and fibroids. We invite everyone to join us in this important discussion.
Join us in Basel, Switzerland June 6th and 7th!
